Cognitive Behavioral Treatment of Pediatric Trichotillomania

This study has been completed.
Information provided by:
National Institute of Mental Health (NIMH) Identifier:
First received: August 9, 2002
Last updated: November 17, 2005
Last verified: November 2005
This study will compare the effectiveness of cognitive-behavior therapy (CBT) to a minimal attention control (AC) condition for treatment of pediatric trichotillomania (TTM).

Condition Intervention Phase
Behavioral: Cognitive-Behavior Therapy
Phase 1

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Cognitive Behavioral Treatment of Pediatric Trichotillomania

Resource links provided by NLM:

Further study details as provided by National Institute of Mental Health (NIMH):

Estimated Enrollment: 24
Study Start Date: January 2001
Estimated Study Completion Date: December 2003
Detailed Description:

TTM is a persistent impulse control disorder in which the individual acts on urges to pull out his or her own hair. Onset typically occurs by adolescence, and TTM is often associated with significant functional impairment and distress. CBT is a type of psychotherapy designed to change problematic behaviors and thinking. It includes self-monitoring of hair-pulling urges and homework assignments to practice the use of cognitive and behavioral strategies.

Participants are assigned randomly to receive either CBT or AC for 8 weeks. Participants assigned to CBT receive weekly 1-hour sessions of CBT for 8 weeks; participants assigned to AC receive 6 telephone contacts and 2 in-person sessions for 8 weeks. After 8 weeks, CBT participants who respond to treatment enter Phase II, which lasts an additional 8 weeks and includes 4 in-person maintenance sessions. AC participants who are still symptomatic after 8 weeks are offered CBT.


Ages Eligible for Study:   8 Years to 17 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Primary diagnosis of Trichotillomania
  • Minimum symptom duration of 6 months
  • Presence of a stable parent or guardian

Exclusion Criteria:

  • Other primary psychiatric diagnosis
  • Bipolar illness, pervasive developmental disorder, thought disorder, current major depression, ADD/ADHD
  • Concurrent psychotherapy
  • Currently receiving psychotropic medications
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00043563

United States, Pennsylvania
Center for the Treatment and Study of Anxiety
Philadelphia, Pennsylvania, United States, 19104
Sponsors and Collaborators
National Institute of Mental Health (NIMH)
  More Information

No publications provided Identifier: NCT00043563     History of Changes
Other Study ID Numbers: R21 MH61457, DSIR CT-S
Study First Received: August 9, 2002
Last Updated: November 17, 2005
Health Authority: United States: Federal Government

Keywords provided by National Institute of Mental Health (NIMH):
Cognitive-behavior Therapy
Minimal Attention Control

Additional relevant MeSH terms:
Impulse Control Disorders
Mental Disorders processed this record on November 24, 2015